Literature DB >> 4050334

Gliosarcomas: histological, immunohistochemical, ultrastructural, and tissue culture studies.

F Slowik, K Jellinger, L Gaszó, J Fischer.   

Abstract

Thirty-nine cases of gliosarcomas, two initiating as fibrosarcomas, 25 as mixed gliomas and sarcomas, and 12 as anaplastic gliomas with secondary sarcomas, were studied by light microscopy, immunohistochemistry, using GFAP, factor VIII/RAg, and Ulex europaeus I agglutinin (UEA I), electron microscopy and tissue culture. GFAP was found variably positive in the glial areas; F VIII/RAg and UEA I, markers of both normal and neoplastic endothelial cells and their derivatives, were found in vessels of both gliomatous and sarcomatous parts of GS, less intensive in hyperplastic glomeruloid structures and, with decreasing intensity, in adjacent fibrosarcomatous areas, while UEA I, giving stronger reaction than F VIII/RAg, was occasionally demonstrated in sarcomatous cells. In vitro studies confirmed previous data of a separate growth of glial and mesenchymal cells with a divergent migratory speed. Electron microscopy demonstrated the frequent close admixture of glial and mesenchymal tumor cells, which showed the feature of either fibrosarcoma or angiosarcoma. The frequent resemblance of the latter with endothelial cells was supported by the occasional demonstration of Weibel-Palade-like bodies in both vascular endothelial and adjacent sarcomatous cells. These observations confirm the hypothesis that at least part of the sarcomatous components in many GS originate from vascular endothelial proliferation and obviously represent the final stage of a process starting with the endothelial hyperplasia in anaplastic gliomas.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4050334     DOI: 10.1007/BF00687802

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  38 in total

1.  The endothelial hyperplasia of the cerebral blood vessels with brain tumors, and its sarcomatous transformation.

Authors:  I FEIGIN; L B ALLEN; L LIPKIN; S W GROSS
Journal:  Cancer       Date:  1958 Mar-Apr       Impact factor: 6.860

2.  Contribution of immunohistochemistry to diagnostic problems of human cerebral tumors.

Authors:  L F Eng; L J Rubinstein
Journal:  J Histochem Cytochem       Date:  1978-07       Impact factor: 2.479

3.  Ultrastructure of a composite glioma-sarcoma of the brain.

Authors:  C E Peña; R Felter
Journal:  Acta Neuropathol       Date:  1973       Impact factor: 17.088

4.  Lectins as fluorescence microscopic markers for saccharides in the human kidney.

Authors:  H Holthöfer; I Virtanen; E Pettersson; T Törnroth; O Alfthan; E Linder; A Miettinen
Journal:  Lab Invest       Date:  1981-11       Impact factor: 5.662

5.  Ultrastructural localization of lectin receptors on cerebral endothelium.

Authors:  S Nag
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

6.  Neoplasms of mixed mesenchymal and neuroepithelial origin. Relation to "monstrocellular sarcoma" or "giant-celled glioblastoma".

Authors:  S Shuangshoti; M G Netsky
Journal:  J Neuropathol Exp Neurol       Date:  1971-04       Impact factor: 3.685

7.  Clinical and pathological study of 24 cases of gliosarcoma.

Authors:  R A Morantz; I Feigin; J Ransohoff
Journal:  J Neurosurg       Date:  1976-10       Impact factor: 5.115

8.  Ulex europaeus I lectin as a marker for vascular endothelium in human tissues.

Authors:  H Holthöfer; I Virtanen; A L Kariniemi; M Hormia; E Linder; A Miettinen
Journal:  Lab Invest       Date:  1982-07       Impact factor: 5.662

9.  Factor VII related antigen as an endothelial cell marker in benign and malignant diseases.

Authors:  M Sehested; K Hou-Jensen
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1981

10.  NEW CYTOPLASMIC COMPONENTS IN ARTERIAL ENDOTHELIA.

Authors:  E R WEIBEL; G E PALADE
Journal:  J Cell Biol       Date:  1964-10       Impact factor: 10.539

View more
  21 in total

1.  Sarcomatous proliferation of the vasculature in a subependymoma: a follow-up study of sarcomatous dedifferentiation.

Authors:  D N Louis; E T Hedley-Whyte; R L Martuza
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

2.  Multifocal spinal angiosarcoma after chordotomy.

Authors:  W Kristoferitsch; K Jellinger
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

3.  Glioblastoma with sarcomatous component associated with myxoid change. A histochemical, immunohistochemical and electron microscopic study.

Authors:  M Kishikawa; N Tsuda; H Fujii; I Nishimori; H Yokoyama; M Kihara
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

4.  Immunohistochemical investigation of collagen subtypes in human glioblastomas.

Authors:  W Paulus; W Roggendorf; D Schuppan
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

5.  Contribution of histiocytic cells to sarcomatous development of the gliosarcoma. An immunohistochemical study.

Authors:  N Kochi; H Budka
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

6.  Cellular components of microvascular proliferation in human glial and metastatic brain neoplasms. A light microscopic and immunohistochemical study of formalin-fixed, routinely processed material.

Authors:  P Wesseling; J J Vandersteenhoven; B T Downey; D J Ruiter; P C Burger
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

7.  Gliosarcomas: analysis of 11 cases do two subtypes exist?

Authors:  Maurizio Salvati; Emanuela Caroli; Antonino Raco; Felice Giangaspero; Roberto Delfini; Luigi Ferrante
Journal:  J Neurooncol       Date:  2005-08       Impact factor: 4.130

Review 8.  Gliofibromas (including malignant forms), and gliosarcomas: a comparative study and review of the literature.

Authors:  M Cerda-Nicolas; J J Kepes
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

9.  Cerebral gliosarcoma: prognostic factors.

Authors:  L Cervoni; P Celli
Journal:  Neurosurg Rev       Date:  1996       Impact factor: 3.042

Review 10.  Primary gliosarcoma: key clinical and pathologic distinctions from glioblastoma with implications as a unique oncologic entity.

Authors:  Seunggu J Han; Isaac Yang; Tarik Tihan; Michael D Prados; Andrew T Parsa
Journal:  J Neurooncol       Date:  2009-07-18       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.